Cellevolve Announces Expansive Global Collaboration with Seattle Children's Therapeutics to Advance Research for Childhood Brain Cancers - Financial Post
3/9/2022 12:00:00 AM3 years 1 month ago
by Business Wire
by Business Wire
The Company Also Announced Immunotherapy Pioneer Dr. Michael Jensen as Founding Advisor
Author of the article: Dr. Michael Jensen, Founding Advisor, CellevolveBusiness Wire Article content The Company Also Announced Immunotherapy Pioneer Dr. Michael Jensen as Founding Advisor This … [+8477 chars]
full article...